Search results for "Addiction, Abuse, and Misuse"


 
Results 1 - 7 of about 7 for "Addiction, Abuse, and Misuse".

November/December 2017 | ACP Internist

ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.

QD: News Every Day--FDA announces label changes, postmarket study for long-acting opioids : ACP Internist

Labeling changes for opioids announced by the FDA will update indications for extended release and long-acting opioids so that they are int...

INT1113_15-ITN-JKS

addiction, abuse, and misuse, even at rec-. ommended doses, and because of the. ... to further assess the risks of misuse, abuse,. hyperalgesia, addiction, overdose and.

May 2018 | ACP Internist

ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.

New labeling on long-acting opioids, fluoroquinolones | ACP Internist

This regulatory update covers a labeling change for all long-acting opioid analgesics, and another on fluoroquinolone drugs to better describe the serious side effect of peripheral neuropathy.

A ‘smart’ approach to performance drugs | ACP Internist

An increasing prevalence of the use of cognitive-enhancing substances, or so-called “smart drugs,” among healthy people has raised concerns among internists and medical ethicists.

Broad efforts needed to reduce alcohol-related traffic deaths | ACP Internist

Internists can intervene in alcohol-related traffic deaths by counseling patients against riding with impaired drivers, promoting local sobriety checkpoints, and supporting mass-media campaigns against alcohol-impaired driving, among other measures.

Prev   1   Next